Dechra Pharmaceuticals PLC Additional Listing (4416T)
12 October 2017 - 8:39PM
UK Regulatory
TIDMDPH
RNS Number : 4416T
Dechra Pharmaceuticals PLC
12 October 2017
12 October 2017
Dechra(R) Pharmaceuticals PLC
(Dechra or the Company)
Additional Listing
An application has been made to the Financial Conduct Authority
and the London Stock Exchange for a total of 80,000 ordinary shares
of 1 pence each (the "Shares") to be admitted to the Official
List.
These Shares are being reserved under a block listing and will
be issued pursuant to the following scheme:
Scheme Shares
Save As You Earn (SAYE) scheme 80,000
These Shares will rank pari passu with the Company's existing
shares in issue. It is expected that admission will become
effective on 13 October 2017.
For further information
For further information, please contact:
Dechra Pharmaceuticals PLC
Melanie Hall, Company Secretary
Telephone number: +44 (00 1606 814730
Email: corporate.enquiries@dechra.com
About Dechra
Dechra is an international specialist veterinary pharmaceuticals
and related products business. Our expertise is in the development,
manufacture, and sales and marketing of high quality products
exclusively for veterinarians worldwide. The majority of Dechra's
products are focused on key therapeutic categories where we have
leading market positions, and many of our products are used to
treat medical conditions for which there is no other effective
solution or have a clinical or dosing advantage over competitor
products. For more information, please visit: www.dechra.com.
Trademarks
Trademarks appear throughout this document in italics. Dechra
and the Dechra "D" logo are registered trademarks of Dechra
Pharmaceuticals PLC.
This information is provided by RNS
The company news service from the London Stock Exchange
END
ALSLIFVAIELFLID
(END) Dow Jones Newswires
October 12, 2017 05:39 ET (09:39 GMT)
Dechra Pharmaceuticals (LSE:DPH)
Historical Stock Chart
From Apr 2024 to May 2024
Dechra Pharmaceuticals (LSE:DPH)
Historical Stock Chart
From May 2023 to May 2024
